Pluma, Jayson .
HRN: 21-60-92 Sex: MalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
07/03/2024
PIPERACILLIN + TAZOBACTAM 2.25G (VIAL)
07/03/2024
07/09/2024
IVTT
2.25 G
Q6
Infected Wound,sepsis, Renal Dose
Waiting Final Action
Indication: Empiric Type of Infection: BloodstreamSkin & Soft Tissue Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes